PURA - Puration Enters $1.7 Billion European CBD Market With New Distribution Agreement For Its EVERx CBD Sports Water
October 01 2019 - 9:28AM
InvestorsHub NewsWire
PURA – Puration Enters $1.7 Billion
European CBD Market With New Distribution Agreement For Its EVERx
CBD Sports Water
DALLAS, TX -- October 1, 2019 --
InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) today released a presentation detailing its recently
announced new distribution agreement for its EVERx CBD
Sports Water in Europe anticipated to generate $4 million in
annual revenue. The presentation has been prepared by the
company’s CEO, Brian Shibley, and is available in its entirety
below:
EVERx CBD Sports
Water and The New European Marketing
Campaign
Two weeks ago,
PURA kicked off a European marketing campaign for its EVERx CBD
Sports Water at Arnold Schwarzenegger’s Arnold Sports Festival
Europe in Barcelona. EVERx was
officially launched for the first time ever at the Arnold Classic
in Columbus, Ohio in
2017. EVERx now participates at the Arnold Sports
Festival events worldwide.
EVERx today is
the leading CBD infused sports nutrition beverage with over $1
million in sales in 2018 and over $1 million in sales in the first
six months of 2019 and targeting $4 million in sales by 2019-year
end.
The $4 million
anticipated from the new distribution agreement is separate from
the current $4 million 2019 sales
target.
If possible,
the European cannabis legalization environment is more chaotic than
in the United States.
Forbes reports:
“In the
European Union, the legal status of cannabis varies by country.
Medical cannabis is legal in Germany, Czech Republic, Italy and
Malta. The UK is also moving to legalize medical cannabis. The
status of edibles in the EU is legally
unclear.”
Nevertheless,
the Brightfield Group predicts the EU market for
CBD to reach $1.7 billion by
2023.
PURA has
specialized in navigating the market dynamics associated with the
early market adoption of cannabis products where rules and
regulations are not clear and ever changing yet market demand has
sent a clear message that consumers are ready for and looking for
cannabis products. PURA’s business comes from a spin-off of a
cannabis extraction business previously owned by North American
Cannabis Holdings, Inc (USOTC:
USMJ) which was started in 2013, early on in the cannabis
consumer market. PURA management has garnered a wealth of
knowledge and experience anticipated to help the company navigate
the rapidly growing opportunity in
Europe.
In addition to
the market experience PURA has gained from its early entry, PURA
has also amassed substantial product experience. Not all CBD
extracts are created equal and the infusion of CBD into a beverage
or edible is not as easy as simply mixing CBD in a mixing
bowl. PURA has experienced shelf-life problems, among other
issues and in turn, resolved the problems. PURA’s hands on
experience and US market presence has made PURA a target of
interest of more than one major beverage brand
name.
PURA’s EVERx
CBD Sports Water and new CBD beverages in the works which will be
included in the new distribution agreement, benefit from PURA’s
sole license of a U.S. Patented Cannabis Extraction Process for
beverage infusion from Kali-Extracts, Inc. (USOTC:
KALY). USMJ originally entered into a contract with NCM
Biotech, the company that originally owned the Patented Cannabis
Extraction Process. USMJ spun the contract off to PURA and
NCM Biotech was subsequently acquired by
KALY.
New European
Distributor
Truth be told,
the new distribution agreement announced last week is not PURA’s
first experience with the new distributor. PURA has
previously shipped EVERx CBD Sports Water to this distributor and
conducted test marketing. The new agreement was not as simple
and easy as the announcement last week may have made it
sound. The agreement has been in the works for about a year
and a half. The success of EVERx CBD Sports Water’s
presentation at the Arnold Sport Festival in Barcelona two weeks
ago sealed the deal.
Over the last
year and a half, and in conjunction with the test marketing, the
distributor and PURA management have a good deal of confidence in
the anticipated market opportunity for $4 million in sales
annually. With the first shipment going out later this month,
the $4 million annual projection can be validated and updated with
Q4 sales.
Among other
outlets, the distributor supplies a major
multibillion-dollar grocery
chain with a majority of sales in the UK and
Spain.
Some shareholders have already inquired as
to why PURA has not yet released the name of the distributor or the
corresponding grocery chain. Candidly, PURA has released such
information in the past early on related to new contract
announcements and experienced consequential difficulties, some with
unfortunate outcomes. The release of client and partner
information almost always results in unsolicited calls to PURA’s
new clients and partners. The calls very in nature, but are
periodically considered an unwelcome burden by PURA’s new clients
and partners. While the intention is not to keep the new
client and partner a secret forever, which would probably not be
possible anyway, PURA management would like to mature the
partnership and client relationship a bit before causing an
increased call volume for the new client and
partner.
To learn more about EVERx CBD Sports
Water, you can find it available for purchase on line
at www.USMJ.com
hosted by PURA’s partner North
American Cannabis Holdings, Inc. (USOTC:
USMJ).
For more information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2023 to Sep 2024